New acute treatments for headache

por Rapoport, Alan M.
Publicado 2010

Cluster headache in Greece: an observational clinical and demographic study of 302 patients

por Vikelis, Michail, Rapoport, Alan M.
Publicado 2016

Hemicrania continua

por Rapoport, Alan M., Bigal, Marcello E.
Publicado 2004

All triptans are not the same

por Rapoport, Alan M., Tepper, Stewart J.
Publicado 2001

New players in the preventive treatment of migraine

por Mitsikostas, Dimos D., Rapoport, Alan M.
Publicado 2015

Neurobiology of migraine progression

por Rattanawong, Wanakorn, Rapoport, Alan, Srikiatkhachorn, Anan
Publicado 2022

Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine

por Vikelis, Michail, Mitsikostas, Dimos D, Rapoport, Alan M
Publicado 2012

Strategies of care for acute treatment of migraine

por Tepper, Stewart J., Rapoport, Alan M., Sheftell, Fred
Publicado 2002

Migraine and episodic Vertigo: a cohort survey study of their relationship

por Lampl, Christian, Rapoport, Alan, Levin, Moris, Bräutigam, Elisabeth
Publicado 2019

The effect of weight, body mass index, age, sex, and race on plasma concentrations of subcutaneous sumatriptan: a pooled analysis

por Munjal, Sagar, Gautam, Anirudh, Rapoport, Alan M, Fisher, Dennis M
Publicado 2016

Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study

por Landy, Stephen, Munjal, Sagar, Brand-Schieber, Elimor, Rapoport, Alan M.
Publicado 2018

Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: an 8-week open-label extension study

por Landy, Stephen, Munjal, Sagar, Brand-Schieber, Elimor, Rapoport, Alan M.
Publicado 2018

DFN-02, Sumatriptan 10 mg Nasal Spray with Permeation Enhancer, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Study Assessing Functional Disab...

por Lipton, Richard B., Munjal, Sagar, Brand-Schieber, Elimor, Rapoport, Alan M.
Publicado 2019

On the Application of a Diffusive Memristor Compact Model to Neuromorphic Circuits

por Cisternas Ferri, Agustín, Rapoport, Alan, Fierens, Pablo I., Patterson, German A., Miranda, Enrique, Suñé, Jordi
Publicado 2019

A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of epis...

por Munjal, Sagar, Brand-Schieber, Elimor, Allenby, Kent, Spierings, Egilius L.H., Cady, Roger K., Rapoport, Alan M.
Publicado 2017

Remote electrical neuromodulation (REN) in the acute treatment of migraine: a comparison with usual care and acute migraine medications

por Rapoport, Alan M., Bonner, Jo H., Lin, Tamar, Harris, Dagan, Gruper, Yaron, Ironi, Alon, Cowan, Robert P.
Publicado 2019

Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification

por Charles, James A., Peterlin, B. L., Rapoport, Alan M., Linder, Steven L., Kabbouche, Marielle A., Sheftell, Fred D.
Publicado 2009

Efficacy and safety of erenumab in women with a history of menstrual migraine

por Pavlovic, Jelena M., Paemeleire, Koen, Göbel, Hartmut, Bonner, Jo, Rapoport, Alan, Kagan, Risa, Zhang, Feng, Picard, Hernan, Mikol, Daniel D.
Publicado 2020

Diagnostic accuracy of an artificial intelligence online engine in migraine: A multi‐center study

por Cowan, Robert P., Rapoport, Alan M., Blythe, Jim, Rothrock, John, Knievel, Kerry, Peretz, Addie M., Ekpo, Elizabeth, Sanjanwala, Bharati M., Woldeamanuel, Yohannes W.
Publicado 2022

Experts’ opinion about the pediatric secondary headaches diagnostic criteria of the ICHD-3 beta

por Özge, Aynur, Abu-Arafeh, Ishaq, Gelfand, Amy A., Goadsby, Peter James, Cuvellier, Jean Christophe, Valeriani, Massimiliano, Sergeev, Alexey, Barlow, Karen, Uludüz, Derya, Yalın, Osman Özgür, Faedda, Noemi, Lipton, Richard B., Rapoport, Alan, Guidetti, Vincenzo
Publicado 2017